Cargando…
Virtual Screening for Potential Inhibitors of Human Hexokinase II for the Development of Anti-Dengue Therapeutics
Dengue fever, which is a disease caused by the dengue virus (DENV), is a major unsolved issue in many tropical and sub-tropical regions of the world. The absence of treatment that effectively prevent further viral propagation inside the human’s body resulted in a high number of deaths globally each...
Autores principales: | Tanbin, Suriyea, Ahmad Fuad, Fazia Adyani, Abdul Hamid, Azzmer Azzar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245486/ https://www.ncbi.nlm.nih.gov/pubmed/35822774 http://dx.doi.org/10.3390/biotech10010001 |
Ejemplares similares
-
Contemporary Strategies and Current Trends in Designing Antiviral Drugs against Dengue Fever via Targeting Host-Based Approaches
por: Ahammad, Foysal, et al.
Publicado: (2019) -
In Silico Screening of Aptamers Configuration against Hepatitis B Surface Antigen
por: Sabri, Mohamad Zulkeflee, et al.
Publicado: (2019) -
Virtual Screening and Biological Activity Evaluation of New Potent Inhibitors Targeting Hexokinase-II
por: Liu, Ruijuan, et al.
Publicado: (2022) -
P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease
por: Ahmed Juvale, Iman Imtiyaz, et al.
Publicado: (2022) -
An S188V Mutation Alters Substrate Specificity of Non-Stereospecific α-Haloalkanoic Acid Dehalogenase E (DehE)
por: Abdul Hamid, Azzmer Azzar, et al.
Publicado: (2015)